Fred Alger Management »

Aeglea Biotherapeutics shares owned by Fred Alger Management

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Fred Alger Management from 13F filings

Historical chart of Fred Alger Management investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Fred Alger Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Fred Alger Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $689k 18k 37.93

More positions owned by Fred Alger Management

Microsoft Corp Common (MSFT)
Nvidia Corp. Common (NVDA)
Amazon Common (AMZN)
Apple Common (AAPL)
Meta Platforms Inc Class A Common (META)
Natera Common (NTRA)
Alphabet Inc Cl C Common (GOOG)
Broadcom Common (AVGO)
Taiwan Semiconductor Common (TSM)
Netflix Common (NFLX)
Visa Inc Class A Shares Common (V)
Applovin Corp Class A Common (APP)
Eli Lilly & Co Common (LLY)
Pinterest Inc Class A Common (PINS)
Gfl Environmental Common (GFL)

View all positions for Fred Alger Management

Top funds holding Aeglea Biotherapeutics

Fairmount Funds Management
Perceptive Advisors
VR Adviser
Braidwell
BlackRock
Commodore Capital
Vanguard Group
Deep Track Capital
State Street Corporation
Goldman Sachs Group
Geode Capital Management
Franklin Resources
Citadel Advisors
Boxer Capital
Driehaus Capital Management

View all funds holding Aeglea Biotherapeutics